Biotech · Private company
Sparrow Pharmaceuticals
Track this companyFree. Adds Sparrow Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials62 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- clofutribenPhase 2 · Type 2 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- SPI-62Phase 2 · Cushing's Syndrome IClinicalTrials.gov · fetched Nov 12, 2026
- SPI-62 dosePhase 2 · Autonomous Cortisol Secretion (ACS)ClinicalTrials.gov · fetched Nov 12, 2026
- 12mg clofutribenPhase 1 · Moderate Renal ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- 2 single oral doses of prednisolonePhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- clofutriben once daily for 16 daysPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- Cortisone-d8Phase 1 · Type 2 Diabetes Mellitus in ObeseClinicalTrials.gov · fetched Nov 12, 2026
- midazolamPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- SPI-62Phase 1 · Type 2 Diabetes Mellitus in ObeseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Clofutriben Pharmacokinetics in Patients With Impaired Renal FunctionPHASE1 · RECRUITING · started Nov 30, 2025ClinicalTrials.gov NCT07227922 · fetched Nov 12, 2026
- Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)PHASE2 · RECRUITING · started Nov 29, 2025ClinicalTrials.gov NCT07296484 · fetched Nov 12, 2026
- Pharmacokinetic Interaction Trial of Clofutriben With Midazolam and PrednisolonePHASE1 · COMPLETED · started Oct 3, 2025ClinicalTrials.gov NCT07226635 · fetched Nov 12, 2026
- SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal TumorPHASE2 · COMPLETED · started Jul 1, 2023ClinicalTrials.gov NCT05436639 · fetched Nov 12, 2026
- SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's SyndromePHASE2 · COMPLETED · started Sep 1, 2022ClinicalTrials.gov NCT05307328 · fetched Nov 12, 2026
- A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62PHASE1 · COMPLETED · started Jul 23, 2021ClinicalTrials.gov NCT05409027 · fetched Nov 12, 2026